[ad_1]
AstraZeneca vaccine presentation: I see effort, but not “every effort possible,” Internal Market Commissioner Thierry Breton wrote on Twitter.
“This is not enough for AstraZeneca to meet its first quarter commitments,” he wrote.
“It is time for the AstraZeneca board to fulfill its fiduciary duty and do everything in its power to fulfill AZ’s responsibilities,” he said.
Scanpix Photo / COVID-19 Vaccines
These comments are the latest high point in a heated dispute between the European Commission and the pharmaceutical giant over long delays in vaccine delivery.
Supply problems are hampering vaccination campaigns in European Union countries, which lag far behind the United States, the United Kingdom and Israel in terms of vaccinated populations.
AstraZeneca has acknowledged that it will deliver fewer doses in the first quarter of 2021 than previously planned: 40 million. instead of the 100 million agreed.
The company blamed the stagnant supply on low production at its vaccine factories in EU countries, but expressed hope that it could increase production in the second quarter of this year.
The European Commission suspects that part of the AstraZeneca vaccine doses produced in EU countries have been shipped to the UK, and on January 29 it introduced a scheme to monitor and, if necessary, block COVID-vaccine exports. 19 of the Community.
ZUMA Press / Scanpix nuotr./’AstraZeneca “vaccina”
Europe’s vaccination strategy faced new challenges on Thursday when Denmark, Norway and Iceland announced a temporary suspension of vaccination with AstraZeneca due to blood clots in people who had been vaccinated.
Norway and Iceland are not members of the EU, but belong to the European Economic Area, whose regulatory authority for medicines is the European Medicines Agency (EEA).
The EEA, for its part, has stated that AstraZeneca is safe to use.
The European Commission on Thursday approved the distribution of a single-dose COVID-19 vaccine by US pharmaceutical giant Johnson & Johnson.
The Community has set a target of 70% vaccination for mid-September. adult population of the block.
If you have any questions about the COVID-19 vaccine, please send them to our editorial staff by email. email address [email protected]
[ad_2]
